Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes vision loss starting in childhood, improved patients’ eyesight and the sensitivity of the retina within weeks of treatment. Both of these benefits, however, peaked one to three years after treatment and then diminished, according to results from an ongoing clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health.
Related posts:
- Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
- Medicare Card: Gene Linked to Alzheimer’s Disease Plays Key Role in Cell Survival Scientists have discovered that a gene linked to Alzheimer’s disease may play a beneficial role in cell survival by enabling neurons to clear away toxic proteins. A study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, shows the presenilin 1 (PS1) gene is essential to the function of […]...
- Medicare Card, NIH expands study to better understand kidney disease progression Medicare Card, NIH expands study to better understand kidney disease progression...
- Funded research provides new clues on how ApoE4 affects Alzheimer’s risk Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer’s disease, but the gene’s role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the […]...
- Funded study finds more precise way to estimate kidney function Measuring creatinine and cystatin C — two markers for chronic kidney disease (CKD) — more precisely estimates kidney function than either marker alone, according to a study funded by the National Institutes of Health. Results appear in the July 5 issue of the New England Journal of Medicine....
- Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease...
- Medicare Card, Batten disease may benefit from gene therapy Medicare Card, Batten disease may benefit from gene therapy...
- Medicare Card, Researchers find potential new gene therapy for blinding disease Medicare Card, Researchers find potential new gene therapy for blinding disease...
- Medicare Card, Gene therapy shows promise for treating Niemann-Pick disease type C1 Medicare Card, Gene therapy shows promise for treating Niemann-Pick disease type C1...
- Medicare Card – Retinal prion disease study redefines role for brain cells National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice. In contrast, the study findings indicated that microglia might delay disease progression. […]...
- Medicare Card, Study points to possible treatment for lethal pediatric brain cancer Medicare Card, Study points to possible treatment for lethal pediatric brain cancer...
- Medicare Card, Gene therapy staves off blindness from retinitis pigmentosa in canine model Gene therapy preserved vision in a study involving dogs with naturally occurring, late-stage retinitis pigmentosa, according to research funded by the National Eye Institute (NEI), part of the National Institutes of Health. The findings contribute to the groundwork needed to move gene therapy forward into clinical trials for people with the blinding eye disorder, for […]...
- Gene therapy helps patients with hemophilia B An experimental gene therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. The therapy could give patients a long-term solution for preventing prolonged bleeding episodes and spontaneous bleeding....
- Rare gene glitch may hold clues for schizophrenia — NIH-funded study Rare gene glitch may hold clues for schizophrenia -- NIH-funded study...
- Medicare Card, Risk gene for Alzheimer’s disease associated with lower brain amyloid Medicare Card, Risk gene for Alzheimer’s disease associated with lower brain amyloid...